Ex vivo assays for Hematologic Malignancies
Vivia has overcome shortcomings of >20 years measuring drug
sensitivity in patient samples
  • Automation capable of measuring up to 2,000 points per sample, and substantially lowering errors.
  • Selective evaluation of drug effects on cancer cell subpopulations.
  • Measuring of % live cells, not apoptotic
  • Including kinetic activity
  • Access to AML, MM, CLL, ALL and NHL samples and a large collection of cryopreserved samples.